10.8
CiteScore
 
5.3
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Corrigendum
Current Issue
Editorial
Erratum
Full Length Article
Full lenth article
Letter to Editor
Original Article
Research article
Retraction notice
Review
Review Article
SPECIAL ISSUE: ENVIRONMENTAL CHEMISTRY
10.8
CiteScore
5.3
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Corrigendum
Current Issue
Editorial
Erratum
Full Length Article
Full lenth article
Letter to Editor
Original Article
Research article
Retraction notice
Review
Review Article
SPECIAL ISSUE: ENVIRONMENTAL CHEMISTRY
View/Download PDF

Translate this page into:

ORIGINAL ARTICLE
5 (
4
); 523-526
doi:
10.1016/j.arabjc.2010.09.021

1H and 13C NMR spectra of condensed benzimidazole and imidazobenzodiazepines

Laboratoire de Chimie Bioorganique, Faculté des Sciences, BP20, El Jadida, Maroc 24000, Morocco
Laboratoire de Chimie Organique Hétérocyclique, Faculté des Sciences, Avenue Ibn Battouta, Rabat, Maroc 10000, Morocco
Laboratoire de Synthèse et Electrosynthèse Organique, Université de Rennes1, Avenue Général Leclerc, 35042 Rennes, France

*Corresponding author. Tel.: +212 523343003; fax: +212 523342187 elkihelabdellatif1@yahoo.fr (A. El kihel)

Disclaimer:
This article was originally published by Elsevier and was migrated to Scientific Scholar after the change of Publisher.

Available online 23 September 2010

Abstract

Benzimidazoles are heterocyclic compounds that have awakened great interest during the last few years because of their proven biological activity as antiviral, antimicrobial, and antitumoral agents. For this reason, the development of a systematic NMR study of condensed benzimidazole compounds constitutes a significant tool in understanding the molecular dynamics and the structural parameters that govern their behavior. The 1H and 13C NMR spectra of new imidazobenzodiazepines were investigated. Based on the study of NMR chemical shifts, we discuss the environmental effect of the nucleus 13C. The correlation 1H–13C proved to be a useful method for distinguishing the assignment of carbon.

Keywords

Benzimidazole
Imidazobenzodiazepines
1H and 13C NMR
1H–13C correlation
1

1 Introduction

The benzimidazole nucleus and its derivatives are known to play extremely crucial roles in the structures and functions of a number of biologically important molecules, generally by virtue of their being coordinated to metal ions. The incorporation of the benzimidazole nuclei is an important synthetic strategy in drug discovery (Townsend, 1976). The high therapeutic properties of the related drugs have encouraged the medicinal chemists to synthesize the large number of novel chemotherapeutic agents (Kleeman et al., 1999). Pharmaceutical properties including: antiviral (Cheng et al., 2005), antitumoral (Yang et al., 2009; Charlson et al., 1973), antifungal and antimycotic (Walker et al., 1978), antihistaminic and antiallergic (Nakano et al., 2000), antimicrobial (Marquis et al., 2006), antihelminthic (Mavrova, 2006) and spasmolytic activity (Navarrete-Vázquez et al., 2006). These different applications have attracted many experimentalists and theorists to investigate the spectroscopic and structural properties of benzimidazole (Mohan, 1991; Klots et al., 1997; Morsy et al., 2002) and some of its derivatives (Yurdakul and Yilmaz, 1999).

In this work, we report the study of NMR spectra of condensed benzimidazoles. We have previously described the synthesis of 4-(2,5,6-trimethyl-1H-benzo[d]imidazol-7-ylamino)pent-3-en-2-one 1a, ethyl 3-(2,5,6-trimethyl-1H-benzo[d]imidazol-7-ylamino)but-2-enoate 1b, 4-acetonylidene-5-acetyl-2,6,8,9-tetramethyl-7H-imidazo-[1,5,4-e,f][1,5]-benzodiazepine 2a and 4-acetonylidene-5-ethoxycarbonyl-2,6,8,9-tetramethyl-7H-imidazo-[1,5,4-e,f][1,5]-benzodiazepine 2b (El kihel et al., 2008). The NMR parameters of these heterocycles are reported in this paper.

2

2 Results and discussion

A variety of works are reported about the NMR of benzimidazole derivatives (Embrey and Craik, 1995; Infante-Castillo et al., 2008; El kihel et al., 2005) The 13C NMR spectra and the charge density of carbon for the benzimidazole were reported by Pugmire and Grant (1971). The chemical shifts of carbon 13 for some benzimidazoles substituted in position 5 were published (Mathias and Overberger, 1978; Fruchier et al., 1980; Blackburn et al., 1982; Lopyrev et al., 1981, 1985). Other works have reported the NMR of some bisbenzimidazoles and condensed benzimidazoles (Dall’Oglio et al., 2002; Alcade et al., 1991; Goljer et al., 1985). After the study of the behavior of the 13C NMR spectra in the benzimidazole series (Goljer et al., 1985), we are interested to report our contribution in this area by using NMR spectroscopy for the elucidation of carbon13 chemical shifts of these benzimidazole derivatives. We have studied the influence of the substituents on the 13C NMR spectra of these compounds. The complete assignment of the resonances of the 13C NMR spectra of the benzimidazole derivatives was carried out by selective decoupling, NOE, and H, C-COSY experiments (see Figs. 1 and 2).

The numbering of the compunds for the 1HNMR assignments.
Figure 1
The numbering of the compunds for the 1HNMR assignments.
The numbering of the compounds for the 13CNMR assignments.
Figure 2
The numbering of the compounds for the 13CNMR assignments.

3

3 Results and discussion

Tables 1 and 2 give the 1H and 13C NMR data, respectively; of 1a, 1b, 2a and 2b.

Table 1 1H NMR data of the studied compounds.
Proton Compounds
1a 1b 2a 2b
H1 10.19(br s, cyclic NH) 9.99(br s, cyclic NH)
H4 7.21(s) 7.22(s) 7.36(s) 7.43(s)
H10 2.44(s, CH3) 2.45(s, CH3) 2.54(s, CH3) 2.45(s, CH3)
H11 2.31(s, CH3) 2.33(s, CH3) 2.42(s, CH3) 2.37(s, CH3)
H12 2.00(s, CH3) 2.10(s, CH3) 1.95(s, CH3) 1.67(s, CH3)
H14 5.25(s, olefinic H) 4.69(s, olefinic H)
H16 1.87(s, CH3) 1.22(t, CH3), 1.79(s, CH3) 1.24(t, CH3)
4.07(q, CH2) 4.21(q, CH2)
H17 2.13(s, CH3) 2.16(s, CH3) 2.37(s, CH3) 1.95(s, CH3)
H18 12.23(s, NH) 12.32(s, NH) 15.81(s, NH) 12.54(s, NH)
H19 6.20(s, olefinic H) 6.28(s, olefinic H)
H21 1.80(s, CH3) 1.69(s, CH3)
Table 2 13C NMR data of the studied compounds.
Carbon Compounds chemical shifts (ppm)
1a 1b 2a 2b
C2 150.8 159.6 145.2 146.7
C4 110.2 110.2 99.7 112.9
C5 129.8 126.4 132.3 131.1
C6 124.8 117.2 126.8 125.9
C7 130.1 130.1 134.3 133.6
C8 125.6 120.8 128.4 126.1
C9 147.5 150.5 139.1 138.0
C10 14.5 20.6 14.4 14.4
C11 20.5 19.5 18.2 17.1
C12 13.8 14.5 13.3 13.9
C13 162.7 161.6 147.3 149.8
C14 95.8 83.0 124.7 123.5
C15 194.4 169.7 204.1 166.8
C16 38.5 18.3, 57.8 20.1 13.1, 60.7
C17 28.7 48.6 19.2 19.6
C18 154.1 152.6
C19 105.1 116.6
C20 173.3 174.1
C21 20.3 20.3

The benzimidazole presents a rapid tautomerism which does not allow to obtain all expected signals in the 13C NMR spectra in the case of substituted benzimidazoles by heterocycles(El Kihel et al., 2005).

This phenomenon was not observed for the open chain intermediates 1a and 1b or the condensed benzimidazoles 2a and 2b, the 13C NMR spectra of these compounds present all the expected signals.

For the condensed benzimidazoles as imidazobenzodiazepines, we have studied the chemical shifts of vinyl and carbonyl group in order to see the effect of conjugated system.

For the 13C NMR spectra of compounds 2a and 2b, the conjugated system induces a systematic shielding of the carbonyl group in position 20 (δ = 173.3 ppm for compound 2a and δ = 174.1 ppm for compound 2b) by comparison of the chemical shifts of the carbonyl group in position 15 (δ = 194.4 ppm for compound 1a and δ = 204.1 ppm for compound 2a) while the same observation applies to the carbonyl group of ester with less shielding (δ = 169.7 ppm for compound 1b, δ = 166.8 ppm for compound 2b). We also noted the deshielding of vinyl group CH in compounds 2a and 2b (δ = 105.1 ppm for compound 2a and δ = 116.6 ppm for compound 2b) by comparison of that in compounds 1a and 1b (δ = 95.8 ppm for compound 1a and δ = 83.0 ppm for compound 1b).

4

4 Experimental section

All compounds were characterized by their 1H NMR and 13C NMR spectra as well as by microanalysis or HRMS spectra. NMR spectra were recorded on Bruker ARX 200 (200 MHz for 1H and 50.3 MHz for 13C) spectrometer (Ω-ppm/TMS, J-Hz); for 13C NMR, the multiplicities were determined through DEPT.

References

  1. , , , . Eur. J. Med. Chem.. 1991;26:633.
  2. , , , . Can. J. Chem.. 1982;60:2987.
  3. , , . J. Carbohydr. Res.. 1973;29:89.
  4. , , , . Bioorg. Med. Chem. Lett.. 2005;17:267.
  5. , , , , , . J. Braz. Chem. Soc.. 2002;13(2):251.
  6. , , , , , . Phys. Chem. News. 2005;25:130.
  7. , , , , , , , . Synthetic Commun.. 2008;38:201.
  8. , , . J. Phys. Chem.. 1995;99:4831.
  9. , , , . Ann. Quim.. 1980;76:79.
  10. , , , . Magn. Reson. Chem.. 1985;23(10):877.
  11. , , , . J. Mol. Struct.. 2008;877:10-19.
  12. Kleeman, A., Engel, J., Kutscher, B., Reichert, D., 1999. Pharmaceutical Substances, third ed., Thieme, Stuttgart, New York, p. 726.
  13. , , , . Spectrochim. Acta A. 1997;53:2445.
  14. , , , , , , , . Org. Magn. Reson.. 1981;15:219.
  15. , , , , , , , , , . Magn. Reson. Chem.. 1985;23:301-304.
  16. , , , , , . Arch. Oral Biol.. 2006;51:1015.
  17. , , . J. Org. Chem.. 1978;43:3526.
  18. , , , , , , , . Eur. J. Med. Chem.. 2006;41:1412.
  19. , . Spectrochim. Acta A. 1991;47:1111.
  20. , , , . J. Phys. Chem. A. 2002;106:9196.
  21. , , , , , , , . Bioorg. Med. Chem.. 2000;8:373.
  22. , , , , , , , . Bioorg. Med. Chem. Lett.. 2006;16:4169-4173.
  23. , , . J. Am. Chem. Soc.. 1971;93:1880.
  24. , . Chem. Rev.. 1976;67:533.
  25. , , , , , . Med. Chem.. 1978;21:840.
  26. , , , , , , , . Eur. J. Med. Chem.. 2009;44:1808-1812.
  27. , , . Vib. Spectrosc.. 1999;21:127.
Show Sections